HC SURGICAL SPECIALISTS LIMITED
Incorporated in the Republic of Singapore
Registration No. 201533429G
NOTICE OF RECORD DATE AND DIVIDEND PAYMENT DATES
NOTICE IS HEREBY GIVEN that the Share Transfer Books and Register of Members of HC Surgical Specialists Limited (the "Company") will be closed at 5.00 pm on 3 March 2025 for the purpose of determining shareholders' entitlements to the ordinary tax-exempt (one-tier) interim dividend of Singapore 0.80 cents per ordinary share for the financial year ending 31 May 2025 ("Interim Dividend").
Duly completed transfers of shares received by the Company's Share Registrar, Tricor Barbinder Share Registration Services (a division of Tricor Singapore Pte. Ltd.) at 9 Raffles Place, #26-01 Republic Plaza, Singapore 048619 up to 5.00 pm on 3 March 2025 will be registered to determine shareholders' entitlements to the Interim Dividend.
Shareholders (being depositors) whose securities accounts with The Central Depository (Pte) Limited are credited with shares as at 5.00 pm on 3 March 2025 will be entitled to the Interim Dividend.
The Interim Dividend will be paid on 13 March 2025.
By Order of the Board
Dr. Heah Sieu Min
Executive Director and Chief Executive Officer
Date: 14 January 2025
About HC Surgical Specialists Limited
HC Surgical Specialists Limited (the "Company") was incorporated on 1 September 2015 in Singapore and listed on the Catalist of the Singapore Exchange Securities Trading Limited on 3 November 2016. The Company, its subsidiaries and associated company are a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 18 clinics located throughout Singapore.
This announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.
The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #04-02 Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.